Jaringan Laboratorium Medis

Vol. 6 No. 1 (2024): May 2024
Original Articles

Profile of SGOT SGPT Kreatinine MDR TB on KRMT Wongsonegoro Hospital Semarang

Surati
Poltekkes Kemenkes Semarang
Afifah Khairunnisa
Kemenkes Poltekkes Semarang

Published 2024-05-01

Keywords

  • MDR-TB,
  • Kidney,
  • Liver,
  • Creatinine,
  • SGOT,
  • SGPT levels
  • ...More
    Less

How to Cite

Profile of SGOT SGPT Kreatinine MDR TB on KRMT Wongsonegoro Hospital Semarang. (2024). Jaringan Laboratorium Medis, 6(1), 62-69. https://doi.org/10.31983/jlm.v6i1.10951

CrossMark



Dimensions

If it doesn't Appear, click here



PlumX Metrics



Impact Factor

or, Visit on here

Abstract

Tuberculosis (TB) is an infectious disease caused by infection with the bacterium Mycobacterium tuberculosis. Tuberculosis apabila is not treated immediately or the treatment is not complete can result in complications leading to death. Multidrugs resistant tuberculosis (MDR-TB) is one of the complications where the germ Mycobacterium tuberculosis can no longer bekilled with several Anti-Tuberculosis Drugs (OAT). The prevalence of MDR-TB cases in Semarang City has increased from 35 cases in 2017 to 79 cases in 2018. MDR-TB therapy takes a longer time, which is about 18-24 months. Prolonged exposure to drugs can affect body functions, especially the kidneys and liver organs which play a role in the process of removing toxins and metabolic waste. This study aims to determine the health profile of the kidney and liver organs of MDR TB sufferers through the SGOT SGPT and Creatinine parameters and describe them based on age and age range. This research is adescriptive quantitative research with a cross-sectional approach. Sampling using total samples of 18 patients. The results showed that 33% (n= 6) of patients had increased levels of SGOT and SGPT, while examination of creatinine levels showed that 33% of patients had kidney problems. Men have upnormal SGOT and SGPT levels of 40% ( n=4) compared to women, which is 25% (n=2), while upnormal creatinine levels in men are 40% (n=4) while in women it is 50% (n = 8). Patients over the age of 46 years have the most levels of SGOT SGPT and upnormal creatinine, which is 61% (n=4). The results showed that age and gender had an effect on increasing SGOT SGPT and Creatinine levels in MDR-TB patients.

Downloads

Download data is not yet available.

References

  1. Aini, Q., Yovi,I. and Hamidi, M.Y. (2015). Gambaran efek samping obat anti tuberculosis (oat) lini kedua pada pasien TB-MDR di poliklinik TB-MDR RSUD Arifin Acgmad Provinsi Riau. JOM FK, 1(2), pp. 1-13.
  2. Depkes RI. (2009). Klasifikasi Umur Menurut Kategori. Yankes
  3. Diasys. (2019). Alat (gpt) fs*. November, 5–7.
  4. El Bouazzi, O., Hammi, S., Bourkadi, J. E., Tebaa, A., Tanani, D. S., Soulaymani-Bencheikh, R., Badrane, N., & Bengueddour, R. (2016). First line anti-tuberculosis induced hepatotoxicity: Incidence and risk factors. Pan African Medical Journal, 25, 1–10. https://doi.org/10.11604/pamj.2016.25.167.10060
  5. Govindan N. Angka kejadian hepatotoksisitas pada penderita tuberkulosis paru pengguna obat anti tuberkulosis lini pertama di RSUP Haji Adam Malik tahun 2010. Medan. Universitas Sumatra Utara: (2011). 10│JOM FK Volume 2, No 2, Oktober 2015
  6. ITIS Report. (2020). Mycobacterium tuberculosis. https://www.itis.gov/servlet/SingleRpt/SingleRpt?search_topic=TSN&search_value=963806#null
  7. Kemenkes RI. (2017). Pengobatan pasien tuberkulosis. 1–117.
  8. Kemenkes RI. (2020). Situasi TB di Indonesia. In TB Indonesia. Retrieved September 13, 2020 from https://tbindonesia.or.id/informasi/tentang-tbc/situasi-tbc-di-indonesia-2/
  9. Kemenkes RI. (2020). TB MDR. In TB Indonesia. Retrieved September 13, 2020 from https://tbindonesia.or.id/informasi/teknis/tb-mdr/
  10. Kemenkes RI. (2017). PMK NO. 67 Tentang Penanggulangan Tuberkulosis. 163.
  11. Kementerian Kesehatan Republik Indonesia. (2014). Buku Pedoman Nasional Pengendalian Tuberkuolsis.
  12. Kementerian Kesehatan RI. (2018). Info Datin Tuberculosis. Kementerian Kesehatan RI, 1. Retrieved September 13, 2020 from https://www.depkes.go.id/article/view/18030500005/waspadai-peningkatan-penyakit-menular.html%0Ahttp://www.depkes.go.id/article/view/17070700004/program-indonesia-sehat-dengan-pendekatan-keluarga.html
  13. Kustiana, Uli. (2018). Gambaran Kadar Kreatinin Pada Penderita Tuberkulosis Paru Yang Mendapat Terapi Obat Anti Tuberkulosis (Oat) Di RS. Khusus Paru Provinsi Sumatera Selatan Tahun 2018. Jurusan Analis Kesehatan. Poltekkes Palembang.
  14. Maulina, M. (2018). Zat-zat yang Mempengaruhi Histopatologi Hepar. Unimal Press, 49, 13. http://repository.unimal.ac.id/4189/1/%5BMeutia Maulina%5D Zat Zat Yang Mempengaruhi Histopatologi Hepar.pdf
  15. Saida, S., & Syamsiar, S. (2020). Hubungan Kebiasaan Merokok dan Kondisi Lingkungan dengan Kejadian Tuberkulosis Paru di Wilayah Kerja Puskesmas Guali Tahun 2016 (The Relationship Between Smoking Habits and Environmental Conditions with The Incidence of Pulmonary Tuberculosis in the Work . Medula, 7(1), 20–28. Retrieved May 10, 2020 from https://doi.org/10.46496/medula.v7i1.11488
  16. Sari,,Feby Kumala , Cahyo , Kusyogo, dan Kusumawati, Aditya .(2018). Gambaran Perilaku Pasien Sembuh TB MDR Di Kota Semarang. Jurnal Kesehatan Masyarakat (e-Journal). Vol. 6, No. 5, Oktober 2018 (ISSN: 2356-3346) http://ejournal3.undip.ac.id/index.php/jkm
  17. Samhatul, I., & Bambang, W. (2018). Penanggulangan Tuberkulosis Paru dengan Strategi DOTS Samhatul. Higeia Journal Of Public Health Research And Development, 2(2), 331–341. http://journal.unnes.ac.id/sju/index.php/higeia
  18. Sri, Rahayu & Sukeksi, A. (2017). Hubungan Kadar SGOT-SGPT Pada Pasien TB Pengobatan Fase Awal Di Puskesmas Pati. Repository Unimus.
  19. Wahyuni, T. (2020). Faktor-faktor Yang Berhubungan dengan Kejadian Multidrug Resistant Tuberkulosis (MDR-TB). Skripsi. UNNES.
  20. WHO. (2019). WHO TB Report. WHO Library Cataloguing-in-Publication Data World, 7.
  21. WHO Global Report. (n.d.). TB Profile : Indonesia. Retrieved September 13, 2020 from https://worldhealthorg.shinyapps.io/tb_profiles/?_inputs_&lan=%22EN%22&iso2=%22ID%22
  22. Winadiatri, H. (n.d.). Metabolisme Obat Pada Penyakit Kardiovaskuler Halia Winadiatri. 20, 1–4.